Rainbow Children’s Medicare IPO (Initial Public Offering) entered the Indian primary markets on 27 April 2022 and will be open to bidders till 28 April 2022. Hence, the bidders have two more days to apply for the Public Offer Price. 1595 crores. According to Rainbow Children’s Medicare IPO subscription status, the public offering is subscribed 0.29 times while its retail portion is subscribed 0.48 times. The gray market is also showing positive signs regarding the Rainbow Children’s Medicare IPO. According to market observers, Rainbow Children are available at a premium to Medicare’s stock Today 20 in the gray market.
Rainbow Children Medicare IPO GMP
Market observers said Rainbow Children Medicare IPO GMP (grey market premium) today is 20, which is 5 more than Wednesday’s gray market premium 15. Hence, since the opening of the Rainbow Children’s Medicare IPO subscription, the Rainbow Children’s Medicare IPO has risen by over 33 percent and this has happened despite the weak stock market sentiments. Market observers said the gray market sentiment may improve further as two more days are left for bidding. He added that while the increase in Rainbow Children’s Medicare IPO GMP is modest, it has significance because the status of Rainbow Children’s Medicare IPO membership is not so attractive after the first day’s bidding.
what does this gmp mean
As is Rainbow Children’s Medicare IPO GMP Today 20, means gray market is expecting Rainbow Children Medicare IPO listing 562 ( 542 + 20), which is equivalent to the Rainbow Children’s Medicare IPO price band from 516 542 per equity share.
However, stock market experts say that the investment decision should be made on the basis of the gray market performance of the IPO. He said that the GMP of the IPO is an unofficial data, which has nothing to do with the fundamentals of the company. He advised the bidders to go through the balance sheet of the company and then decide whether they want to invest or not.
Rainbow Children’s Medicare IPO: Apply or Not?
Giving a review of Rainbow Children’s Medicare IPO, Santosh Meena, Head of Research, Swastika Investmart Ltd. said, “Rainbow Children’s Medicare Ltd. (RCML) is a leading multi-specialty Pediatric and Obstetrics and Gynecology hospital chain in India. The model is focused on cost-effective development. Going forward, they may try to expand their hospital network through acquisition of brownfield properties or development of greenfield properties. is a combination of digits and is priced at PE 43.53 per annum is FY 22. Profitability for the 9 months ended 31st December 2021 increased to Rs 126.41 crores from 38.53 crores in the same period last fiscal. Chances may be there That this sudden jump in profitability was due to covid second wave hospitalizations in Q1 FY21-22. Thus we believe that this exponential growth in profits may not continue in future. However, the specific nature of the business, experienced management team high capacity The proven ability to attract, train and retain medical professionals who have well within reach of hospitals in India, make this issue a good fit for long-term investors.”
Disclaimer: The views and recommendations given above are those of individual analysts or broking companies and not of Mint.